Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
29.99
+0.44 (1.49%)
Feb 18, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Central Laboratory Channel
175.65M232.81M314.77M319.35M297.34M
Central Laboratory Channel Growth
-24.55%-26.04%-1.44%7.40%7.63%
In-Hospital Channel
224.49M188.70M175.30M165.12M117.87M
In-Hospital Channel Growth
18.97%7.65%6.17%40.08%34.44%
Pharma Research and Development Channel
115.68M115.92M73.17M23.39M14.69M
Pharma Research and Development Channel Growth
-0.21%58.42%212.79%59.26%-17.22%
Total
515.82M537.44M563.24M507.86M429.90M
Total Growth
-4.02%-4.58%10.90%18.13%12.64%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
People’s Republic of China (PRC)
510.24M534.93M553.30M504.05M429.90M
People’s Republic of China (PRC) Growth
-4.62%-3.32%9.77%17.25%-
United States
5.58M2.51M9.93M3.81M-
United States Growth
122.62%-74.76%160.73%--
Total
515.82M537.44M563.24M507.86M429.90M
Total Growth
-4.02%-4.58%10.90%18.13%-
Source: S&P Global Market Intelligence.